止血剂市场规模、份额及成长分析（按类型、剂型、应用、最终用户和地区划分）－2026-2033年产业预测

全球止血剂市场规模预计在 2024 年达到 32 亿美元，从 2025 年的 34.2 亿美元成长到 2033 年的 58.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 6.9%。

全球止血剂市场的发展主要受外科手术和急诊护理中对高效止血需求的不断增长所驱动，这促使产品研发和临床实践发生显着变革。该市场涵盖多种先进的局部用药、贴片、密封剂和流动性材料，可在缝合和电凝等传统方法无效时取代这些产品。生物材料和应用技术的创新正在提升其临床效用，并拓展其在各个外科领域的应用。输血量的减少和復原时间的缩短显着改善了患者的治疗效果。人口老化、手术量的增加以及新兴市场医保报销范围的扩大，都为市场创造了新的商机。各公司正致力于开发更安全的配方和更具成本效益的生产方式，以提高止血剂在各种医疗环境中的应用率并优化治疗效果。

全球止血剂市场驱动因素

全球外科手术数量的不断增长推动了止血产品的需求。随着医疗专业人员在各个医学领域积极寻求可靠的止血方法，这一趋势促使医院和手术中心将先进的止血剂纳入标准手术流程，从而提高手术效率并改善患者预后。随着临床医生对这些产品的了解日益加深，医疗机构也鼓励其使用，更广泛的应用促使製造商拓展分销管道并投资培训计画。这种认知度提升和机构支持的良性循环，显着促进了止血剂市场的持续成长。

限制全球止血剂市场的因素

全球止血剂市场面临许多挑战，主要原因是先进止血剂高成本且医保报销政策不统一。这种经济负担往往会阻碍医疗机构采用更昂贵的止血方案，即使这些方案具有明显的临床效益。受预算限制的采购委员会往往优先考虑价格较低廉的传统产品，阻碍了创新止血产品的市场推广。此外，难以获得稳定的健保报销增加了采购方和生产商的财务风险，最终抑制了投资，延缓了新技术在临床实践中的应用。这反过来又限制了这些产品在患者照护中的接受度和使用。

全球止血剂市场趋势

全球止血剂市场的一个显着趋势是，由于微创手术的日益普及和患者预后改善的推动，先进的生物製药和合成替代製剂的应用日益广泛。与传统止血剂相比，这些创新产品能够快速有效地形成血栓并降低併发症风险，这主要是推动市场对这些产品的青睐。此外，手术量和创伤病例的增加以及人口老化也促进了市场需求。同时，止血产品的技术进步，例如改进的给药系统和特殊配方，也不断重塑市场竞争格局，吸引着主要市场参与者的大量投资和关注。

目录

介绍

• 调查目标
• 市场定义和范围

调查方法

• 调查过程
• 二手资料和一手资料方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争格局概述

市场动态与展望

• 总体经济指标
• 驱动因素和机会
• 限制与挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 影响市场的因素
• 关键投资机会
• 生态系测绘
• 市场吸引力指数（2025）
• PESTEL 分析
• 价值链分析
• 定价分析
• 案例研究
• 监管环境
• 技术评估

全球止血钳市场规模（按类型及复合年增长率划分）（2026-2033 年）

• 活性止血剂
  • 基于凝血酶的止血剂
  • 氧化再生纤维素止血剂
  • 复方止血剂
  • 明胶基止血剂
  • 胶原蛋白蛋白止血剂
  • 其他的
• 被动止血剂
  • 植物来源止血剂
  • 动物源性止血剂
  • 其他的

全球止血钳市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 基质凝胶止血剂
• 止血垫/片
• 海绵止血剂
• 粉状止血剂

全球止血钳市场规模（依应用领域及复合年增长率划分）（2026-2033 年）

• 整形外科手术
• 一般外科
• 神经外科
• 心血管外科
• 重组手术
• 妇科手术
• 创伤管理
• 整形外科
• 牙科治疗
• 其他的

全球止血钳市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心
• 专科诊所
• 护理机构
• 其他的

全球止血剂市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Baxter International
• B.Braun Melsungen AG
• Becton Dickinson and Company
• Integra Life Sciences Holding Corporation
• Johnson and Johnson
• Medtronic Plc
• Pfizer
• Stryker Corporation
• Teleflex Incorporated
• Artivion, Inc.
• Biom'up
• Advanced Medical Solutions Group PLC
• Samyang Corporation
• Haemonetics Corporation
• Ethicon Inc.（a subsidiary of Johnson & Johnson）
• CR Bard, Inc.
• CryoLife, Inc.
• Terumo Corporation
• AngioDynamics, Inc.
• Cohera Medical, Inc.

结论与建议

Global Hemostats Market size was valued at USD 3.2 Billion in 2024 and is poised to grow from USD 3.42 Billion in 2025 to USD 5.83 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global hemostats market is driven by the increasing demand for efficient bleeding control in surgical and emergency settings, leading to a significant evolution in product development and clinical practices. This market includes advanced types such as topical agents, patches, sealants, and flowable materials, which replace traditional methods when sutures or electrocautery fall short. Innovations in biomaterials and application techniques have enhanced clinical utility and broadened their use across various surgical disciplines, significantly improving patient outcomes by reducing transfusions and accelerating recovery times. The aging population, rising surgical volumes, and expanding reimbursement options in emerging markets present new commercial opportunities. Companies are focusing on the development of safer formulations and cost-effective manufacturing to facilitate broader adoption and optimize treatment efficiency in diverse healthcare environments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemostats market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemostats Market Segments Analysis

Global hemostats market is segmented by type, formulation, application, end user and region. Based on type, the market is segmented into Active Hemostats and Passive Hemostats. Based on formulation, the market is segmented into Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats and Powder Hemostats. Based on application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Trauma Management, Plastic Surgery, Dental Treatments and Other Applications. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Nursing Homes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hemostats Market

The demand for hemostatic products is being propelled by the rising number of surgical procedures performed globally, as healthcare professionals actively seek dependable methods to control bleeding in various medical specialties. This trend leads hospitals and surgical centers to adopt advanced hemostats as part of their standard operating procedures, enhancing procedural efficiency and improving patient outcomes. As clinicians become more acquainted with these products and institutions endorse their use, broader adoption occurs, prompting manufacturers to invest in expanding distribution channels and training programs. This cycle of increased familiarity and institutional backing significantly contributes to ongoing growth in the hemostats market.

Restraints in the Global Hemostats Market

The Global Hemostats market faces significant challenges due to high costs associated with advanced hemostatic agents and the variability in reimbursement policies. This financial strain discourages healthcare facilities from adopting these pricier options, even when they offer clear clinical benefits. Budget-conscious procurement committees tend to prioritize more affordable or conventional alternatives, hindering the integration of innovative hemostatic products in the market. Additionally, the difficulties in obtaining consistent reimbursement create increased financial risk for both buyers and manufacturers, which ultimately stifles investment and slows the introduction of new technologies into clinical settings, thereby limiting their acceptance and usage in patient care.

Market Trends of the Global Hemostats Market

A notable trend in the global hemostats market is the increasing adoption of advanced biologics and synthetic alternatives, driven by a rising emphasis on minimally invasive surgical procedures and improved patient outcomes. The shift towards these innovations is largely fueled by their effectiveness in rapid clot formation and reduced risk of complications compared to traditional hemostatic agents. Additionally, the growing prevalence of surgical procedures and trauma cases, alongside an aging population, is propelling demand. Furthermore, technological advancements in hemostatic products, such as enhanced delivery systems and tailored formulations, continue to shape the competitive landscape, attracting significant investment and interest from key players in the market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Hemostats Market Size by Type & CAGR (2026-2033)

• Market Overview
• Active Hemostats
  • Thrombin-based Hemostats
  • Oxidized Regenerated Cellulose-based Hemostats
  • Combination Hemostats
  • Gelatin-based Hemostats
  • Collagen-based Hemostats
  • Other Active Hemostats
• Passive Hemostats
  • Plant-based Hemostats
  • Animal-based Hemostats
  • Other Passive Hemostats

Global Hemostats Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Matrix & Gel Hemostats
• Sheet & Pad Hemostats
• Sponge Hemostats
• Powder Hemostats

Global Hemostats Market Size by Application & CAGR (2026-2033)

• Market Overview
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Trauma Management
• Plastic Surgery
• Dental Treatments
• Other Applications

Global Hemostats Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Nursing Homes
• Others

Global Hemostats Market Size & CAGR (2026-2033)

• North America (Type, Formulation, Application, End User)
  • US
  • Canada
• Europe (Type, Formulation, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Formulation, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Formulation, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Formulation, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Baxter International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B.Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra Life Sciences Holding Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson and Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biom'up
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Medical Solutions Group PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samyang Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon Inc. (a subsidiary of Johnson & Johnson)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.R. Bard, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations